Medically Reviewed | Last Updated: 2025 | Topic: Liraglutide, Weight Loss, Type 2 Diabetes
Key Takeaways
- Liraglutide is a GLP-1 receptor agonist approved for managing type 2 diabetes and chronic weight management.
- It works by mimicking a natural gut hormone to reduce appetite, slow digestion, and regulate blood sugar.
- Clinical trials suggest liraglutide may support weight loss of 5 to 10% or more when combined with diet and exercise.
If you have been hearing the word “liraglutide” more often lately, you are not alone.
Whether your doctor has mentioned it, or you have come across it while researching weight loss or diabetes management, this guide gives you the clear, evidence-backed answers you are looking for.
1. What Is Liraglutide, Exactly?
Liraglutide is a prescription medication that belongs to a class of drugs called GLP-1 receptor agonists (glucagon-like peptide-1 receptor agonists).
It is an injectable drug, meaning it is administered under the skin using a small pen-like device.
The drug was originally developed by Novo Nordisk and approved by the U.S. Food and Drug Administration (FDA) under two different brand names for two different purposes.
Liraglutide was the first GLP-1 receptor agonist approved specifically for weight management in adults.
| Brand Name | Approved Use | Liraglutide Dose | Administration |
|---|---|---|---|
| Victoza | Type 2 diabetes management | Up to 1.8 mg/day | Once-daily injection |
| Saxenda | Chronic weight management | Up to 3.0 mg/day | Once-daily injection |
Source: FDA Drug Approval Summary
It is important to understand that liraglutide is not a weight loss supplement or an over-the-counter remedy.
It is a prescription medication that requires a doctor’s evaluation before use.
2. How Does Liraglutide Work? The Science, Simply Explained
Your gut naturally produces a hormone called GLP-1 (glucagon-like peptide-1) after you eat. Its job is to tell your brain you are full, tell your pancreas to release insulin, and slow the movement of food through your digestive system.
Liraglutide is a synthetic analog of this hormone, meaning it is a lab-made version that mimics GLP-1’s effects but lasts much longer in the body.
Natural GLP-1 breaks down within minutes; liraglutide’s half-life is approximately 13 hours, which is why a single daily injection is enough.
Here is what happens inside the body after a liraglutide injection:
- Brain: The hypothalamus receives signals that reduce hunger and food cravings.
- Pancreas: Insulin secretion increases in response to meals, while glucagon (which raises blood sugar) is suppressed.
- Stomach: Gastric emptying slows, meaning food stays in the stomach longer, prolonging the feeling of fullness.
- Liver: Glucose production is reduced, contributing to better blood sugar control.
A landmark review published in Diabetes, Obesity and Metabolism confirmed that liraglutide’s multi-organ action is what makes it effective for both blood sugar management and weight reduction.
To put it simply: liraglutide does not burn fat directly. It changes how your brain and body respond to food, so you naturally eat less without feeling deprived.
3. What Is Liraglutide Used For? Two Approved Indications
Liraglutide currently has two major approved uses, each backed by extensive clinical data.
Type 2 Diabetes Management (Victoza)
In type 2 diabetes, the body either does not produce enough insulin or does not use it efficiently. Liraglutide (as Victoza) is used alongside diet and exercise to improve blood sugar control in adults.
A major clinical program called the LEAD (Liraglutide Effect and Action in Diabetes) trials demonstrated that Victoza significantly reduced HbA1c levels (a key marker of long-term blood sugar control) compared to other diabetes medications.
Liraglutide may also offer cardiovascular benefits in people with type 2 diabetes.
The LEADER trial (Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results), published in the New England Journal of Medicine, found a 13% reduction in major cardiovascular events in participants using liraglutide compared to placebo. This fits a broader pattern of GLP-1 cardiovascular benefits seen across the drug class.
Chronic Weight Management (Saxenda)
Saxenda (liraglutide 3.0 mg) is approved for chronic weight management in:
- Adults with a body mass index (BMI) of 30 or above (obesity)
- Adults with a BMI of 27 or above who also have at least one weight-related health condition, such as high blood pressure, type 2 diabetes, or high cholesterol
- Adolescents aged 12 and above weighing more than 60 kg with obesity (specific criteria apply)
It is always used alongside a reduced-calorie diet and increased physical activity, not as a standalone solution.
4. How Does Liraglutide Help You Lose Weight? What the Studies Show
Liraglutide reduces weight primarily by suppressing appetite and slowing gastric emptying. Over time, consistently eating less leads to a sustained caloric deficit, which results in fat loss.
The key clinical evidence comes from the SCALE (Satiety and Clinical Adiposity: Liraglutide Evidence in Nondiabetic and Diabetic Individuals) program, a series of trials specifically designed for weight management.
| SCALE Trial | Population | Avg. Weight Loss (Liraglutide) | Publication |
|---|---|---|---|
| SCALE Obesity & Pre-diabetes | Adults with obesity or overweight | ~8% body weight | NEJM, 2015 |
| SCALE Diabetes | Adults with type 2 diabetes & obesity | ~6% body weight | Lancet, 2015 |
| SCALE Maintenance | Adults after low-calorie diet | Sustained loss vs. regain in placebo | Int J Obesity, 2016 |
Sources: SCALE Obesity Trial (NEJM) | SCALE Diabetes Trial (Lancet)
In the SCALE Obesity and Pre-diabetes trial, 63% of participants lost at least 5% of their body weight after 56 weeks of liraglutide treatment, compared to 27% in the placebo group.
Weight loss results vary by individual, and results are best maintained with ongoing lifestyle changes.
Talk with your doctor about whether these outcomes are realistic for your personal health situation.
5. What Is the Liraglutide Dose? A Step-by-Step Escalation Schedule
One of the most important things to understand about liraglutide is that the dose is gradually increased over several weeks.
This titration process helps your body adjust and significantly reduces the risk of side effects, particularly nausea.
| Week | Dose (Saxenda) | Dose (Victoza) | Notes |
|---|---|---|---|
| Week 1 | 0.6 mg/day | 0.6 mg/day | Starting dose — primarily for tolerability |
| Week 2 | 1.2 mg/day | 1.2 mg/day | Therapeutic dose for diabetes (Victoza) |
| Week 3 | 1.8 mg/day | 1.8 mg/day (max) | Max dose for Victoza; continue escalation for Saxenda |
| Week 4 | 2.4 mg/day | N/A | Saxenda escalation continues |
| Week 5+ | 3.0 mg/day (maintenance) | N/A | Maintenance dose for Saxenda |
Source: Saxenda Prescribing Information, FDA
If a patient cannot tolerate the dose increase at any stage, the prescribing doctor may keep the dose steady for an additional week before attempting to increase again.
Never adjust your dose without consulting your doctor.
Important: If you do not tolerate the 3.0 mg dose of Saxenda even after a longer adaptation period, your doctor may consider whether the medication is appropriate for you.
6. How to Inject Liraglutide: The Basic Steps
Liraglutide is administered as a subcutaneous injection, meaning it goes into the fatty tissue just under the skin.
It comes in a pre-filled, multi-dose pen device that is straightforward to use once your healthcare provider has demonstrated the technique.
Always read the full instructions that come with your specific pen device. The steps below are a general overview only.
- Choose an injection site: The abdomen (stomach area), upper thigh, or upper arm. Rotate sites with each injection to prevent skin irritation.
- Prepare the pen: Check the solution is clear and colorless. Attach a new needle for each injection.
- Set the dose: Dial to your prescribed dose.
- Inject: Insert the needle at a 90-degree angle into a pinched fold of skin. Press and hold the button until the dose is delivered.
- Remove safely: Remove the needle and dispose of it in a puncture-resistant sharps container. Never recap a used needle.
- Storage: Store the pen in the refrigerator (2 to 8 degrees Celsius) before first use. After first use, it may be stored at room temperature (below 30 degrees Celsius) for up to 30 days.
If you are unsure about the injection process, ask your doctor or pharmacist to walk you through it at your first appointment. Many clinics offer a brief training session for first-time users.
7. Liraglutide Side Effects: What to Expect and What to Watch For
Like most medications, liraglutide can cause side effects. Most are mild and tend to improve as the body adjusts, especially when the dose is increased gradually.
Knowing what to expect can help you manage them better. The pattern is broadly similar across the class, as covered in our overview of GLP-1 side effects.
Common Side Effects
| Side Effect | How Common | When It Typically Occurs | Management Tips |
|---|---|---|---|
| Nausea | Very common (~40%) | First few weeks | Eat smaller meals; avoid fatty or spicy foods |
| Vomiting | Common (~15%) | Early treatment phase | Stay hydrated; contact doctor if persistent |
| Diarrhoea | Common (~20%) | Early treatment phase | Maintain hydration; usually resolves |
| Constipation | Common (~12%) | Variable | Increase fibre and water intake |
| Headache | Common | Early weeks | Usually mild and self-limiting |
| Injection site reactions | Occasional | At injection site | Rotate injection sites with each dose |
Source: Liraglutide Safety Profile, European Medicines Agency
Serious Side Effects (Seek Medical Attention Promptly)
- Pancreatitis: Severe abdominal pain that may radiate to the back, with or without vomiting. Stop medication and contact your doctor immediately.
- Thyroid tumors: Liraglutide carries a boxed warning for a risk of thyroid C-cell tumors based on animal studies. The relevance to humans is not fully established, but it is contraindicated in people with a personal or family history of medullary thyroid carcinoma or MEN 2.
- Hypoglycemia (low blood sugar): More likely when combined with insulin or sulfonylureas. Symptoms include shakiness, sweating, confusion, and rapid heartbeat.
- Kidney problems: Dehydration from vomiting or diarrhoea may affect kidney function. Stay hydrated and report persistent symptoms.
Always disclose your full medical history and current medications to your prescribing doctor before starting liraglutide. For a full prescribing information document, refer to the FDA label for Saxenda.
8. Liraglutide vs. Semaglutide: How Do They Compare?
Semaglutide (brand names Ozempic for diabetes, Wegovy for weight loss, and Rybelsus as an oral tablet) is the next-generation GLP-1 receptor agonist that followed liraglutide.
Both drugs work through the same mechanism, but there are meaningful differences.
| Feature | Liraglutide | Semaglutide |
|---|---|---|
| Drug class | GLP-1 receptor agonist | GLP-1 receptor agonist |
| Injection frequency | Once daily | Once weekly |
| Max weight loss dose | 3.0 mg/day | 2.4 mg/week (Wegovy) |
| Avg. weight loss (trials) | ~5 to 8% body weight | ~15% body weight (Wegovy) |
| Diabetes brand | Victoza | Ozempic |
| Weight management brand | Saxenda | Wegovy |
| Half-life | ~13 hours | ~1 week |
Source: Comparative GLP-1 Review, Diabetes Obesity Metab.
Semaglutide has shown greater average weight loss in head-to-head and parallel trials.
However, liraglutide has a longer clinical track record and may be preferred in specific patient populations or when weekly injections are not suitable. If you are weighing liraglutide against another once-weekly option, see our side-by-side guide on dulaglutide vs liraglutide. For the newest generation, tirzepatide (sold as Mounjaro), a dual GIP/GLP-1 receptor agonist, has shown even larger average weight loss in trials and is now available in India as another option to discuss with your doctor.
The choice between these medications should always be made with your doctor based on your individual health profile, treatment history, and goals.
9. Liraglutide in India: Brands, Availability, and Getting a Prescription
Liraglutide is available in India under prescription.
With the growing recognition of obesity as a chronic medical condition, the use of GLP-1 medications has been increasing among endocrinologists and diabetologists across major Indian cities.
Available Liraglutide Brands in India
| Brand Name | Manufacturer | Indication | Availability |
|---|---|---|---|
| Victoza | Novo Nordisk | Type 2 diabetes | Widely available, prescription required |
| Saxenda | Novo Nordisk | Weight management | Available; prescription required |
It is important to verify availability and authenticity through a licensed pharmacist. Always purchase from a verified pharmacy and check for the manufacturer’s seal and expiry date on the packaging.
Getting a Prescription in India
Liraglutide is a Schedule H drug in India, which means it requires a valid prescription from a registered medical practitioner. You cannot purchase it over the counter.
To get a prescription, consider consulting:
- An endocrinologist: Specializes in hormones and metabolism, including diabetes and obesity management.
- A diabetologist: A physician with specialized training in diabetes care.
- An obesity medicine physician: Increasingly available in metropolitan hospitals and wellness centers across India.
Many multi-specialty hospitals in cities like Mumbai, Delhi, Bengaluru, Chennai, and Hyderabad have dedicated endocrinology or metabolic health departments where liraglutide prescriptions can be obtained after a proper evaluation. You can also explore the medically supervised MetaGo GLP-1 weight-loss program for an end-to-end pathway.
If you are considering liraglutide for weight loss, your doctor will typically assess your BMI, blood tests, cardiovascular health, and any contraindications before prescribing.
10. Is Liraglutide the Same as Insulin? Clearing a Common Confusion
This is one of the most frequently asked questions about liraglutide, and the answer is straightforward: no, liraglutide is not insulin.
While both are injectable medications used to manage blood sugar, they work in completely different ways.
| Feature | Liraglutide | Insulin |
|---|---|---|
| Drug type | GLP-1 receptor agonist | Hormone replacement |
| Primary action | Stimulates insulin release in response to meals | Directly lowers blood sugar |
| Causes hypoglycemia alone? | Low risk (glucose-dependent) | Yes, possible if overdosed |
| Affects appetite? | Yes, reduces hunger | No direct effect |
| Weight effect? | Usually causes weight loss | Often associated with weight gain |
Because liraglutide only stimulates insulin release when blood sugar is actually elevated (a mechanism called glucose-dependent insulin secretion), the risk of hypoglycemia when used alone is considered low.
This is a meaningful clinical advantage over some other diabetes medications.
The Bottom Line
Liraglutide is a well-researched, clinically approved GLP-1 receptor agonist that may support both blood sugar management and weight loss when used under medical supervision.
It works by mimicking a natural gut hormone to reduce appetite, slow digestion, and regulate insulin.
Whether you are exploring it for type 2 diabetes or chronic weight management, the next step is a conversation with a qualified healthcare professional who can assess whether it is the right option for your health goals.
To find an endocrinologist near you in India, visit the Endocrine Society’s physician directory.
Frequently Asked Questions About Liraglutide
How does liraglutide work for weight loss?
Liraglutide mimics a natural gut hormone called GLP-1 that signals fullness to the brain and slows gastric emptying.
This combination reduces appetite and overall caloric intake over time, leading to gradual weight loss.
It is most effective when combined with a reduced-calorie diet and regular physical activity.
How does liraglutide reduce weight without being an appetite suppressant in the traditional sense?
Unlike older appetite suppressants that act primarily on the central nervous system, liraglutide works through multiple pathways simultaneously: it affects hunger signals in the hypothalamus, slows digestion so meals feel satisfying longer, and regulates insulin release.
The result is reduced food intake without the dependency risks associated with stimulant-based suppressants. A detailed mechanistic review is available in Obesity Reviews.
How to inject liraglutide correctly?
Liraglutide is injected subcutaneously (under the skin) once daily into the abdomen, upper thigh, or upper arm.
Use a new needle each time, rotate injection sites, and store the pen as instructed by your pharmacist.
Always follow the specific instructions provided with your pen device and ask your doctor or pharmacist to demonstrate the technique before your first injection.
What is liraglutide used for beyond weight loss?
Beyond weight management, liraglutide (as Victoza) is approved for improving blood sugar control in adults with type 2 diabetes.
Research also suggests potential cardiovascular benefits, with the LEADER trial demonstrating a reduction in major cardiovascular events in high-risk patients.
Speak with your doctor to understand which indication is relevant to your situation.
Is liraglutide insulin?
No. Liraglutide is not insulin. It is a GLP-1 receptor agonist that stimulates the body’s own insulin release only when blood sugar is elevated, making the risk of hypoglycemia when used alone relatively low.
Insulin, by contrast, directly replaces or supplements the body’s natural insulin and can cause low blood sugar if the dose is not carefully calibrated.
How much does liraglutide cost in India?
The cost of liraglutide varies depending on the brand, pharmacy, and prescribed dose.
For current and accurate pricing, consult a licensed pharmacist or your prescribing doctor. Generic availability and insurance coverage (where applicable) can also affect what you pay out of pocket.
Medical Disclaimer
This article is for informational purposes only and does not constitute medical advice. Liraglutide is a prescription medication. Always consult a qualified healthcare professional before starting, stopping, or changing any medication or treatment plan. Individual results and suitability vary.
